At present, the studies of EX on non-diabetic obesity mainly include 152 cases of simple obesity (weight loss of 5.1 kg) (54), 60 cases of polycystic ovary syndrome (weight loss of 3.2-6.0 kg) (55), and 10 cases of metabolic syndrome (weight loss of 3.7 kg) (56), among which the most common adverse reaction is still vomiting
It is a dual GIP/GLP-1 receptor agonist, meaning it activates two hormone pathways instead of one, which is what distinguishes it from single-pathway GLP-1 drugs like semaglutide
It is normal to feel anxious before your first injection, and this anxiety can amplify pain perception
Because these products are not regulated in the same way as over-the-counter medications, finding a trustworthy vendor is your most important task
1D and E)
As medicine continues to evolve, embracing technology and comprehensive care models will be key to addressing complex health challenges